HAVERHILL PAVILION — History
CCN 224039 | 3-year financial timeline | COVID resilience: 57/100
🛡️ Public data only — no PHI permitted on this instance.
$22M
Latest Revenue (FY2022)
+4.6%
Revenue CAGR (3yr)
2.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $20M | $21M | $22M | +3.3% | +4.6% |
| Operating Expenses | $20M | $21M | $22M | +2.8% | +4.1% |
| Operating Margin | 1.2% | 1.6% | 2.1% | +25.7% | +33.1% |
| Net Income | $0M | $0M | $0M | +29.8% | +39.2% |
| Licensed Beds | 71 | 71 | 71 | +0.0% | +0.0% |
| Total Patient Days | 21,653 | 22,789 | 23,074 | +1.3% | +3.2% |
| Medicare Day % | 20% | 20% | 19% | -7.9% | -3.7% |
| Medicaid Day % | 2% | 3% | 1% | -64.3% | -24.3% |
COVID Impact & Recovery
Resilience Score: 57/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +9.4% ($20M → $22M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.6%
This Hospital
+7.6%
State Avg
Latest Margin
2.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $23M | 2.5% |
| FY2024 (proj) | $24M | 3.0% |
| FY2025 (proj) | $25M | 3.4% |